Posts

Showing posts matching the search for common stock

Blackstone Director Ruth Porat Invests in Common Stock

Image
Blackstone Director Ruth Porat Invests in Common Stock THE MONEYWISE JOURNAL  ·  finance  ·  Thursday, August 13, 2026 This transaction is a significant move, as it highlights the confidence Porat has in the company's future prospects. By MoneyWise Guide Blackstone director Ruth Porat has invested in the company's common stock, purchasing $62,444 worth of shares. This transaction is a significant move, as it highlights the confidence Porat has in the company's future prospects. Key Takeaways Ruth Porat, a director at Blackstone, has invested in the company's common stock. The total value of the investment is $62,444. This move highlights Porat's confidence in Blackstone's future prospects. Metric Value Why it matters Investment Amount $62,444 Demonstrates Porat's confidence in Blackstone's future prospects. Investor Ruth Porat A director ...

An AppFolio Insider Sold on a Preset Plan After Earnings

Image
An AppFolio Insider Sold on a Preset Plan After Earnings THE MONEYWISE JOURNAL  ·  finance  ·  Sunday, August 16, 2026 The transaction took place at a weighted average sale price of $200.49, which is slightly higher than the August 5 market close o… By MoneyWise Guide Evan Pickering, general counsel of AppFolio, Inc., sold 661 shares of Class A Common Stock on August 5, under an automated Rule 10b5-1 plan adopted by him on March 13. The transaction took place at a weighted average sale price of $200.49, which is slightly higher than the August 5 market close of $193.00. This sale reduced Pickering's remaining stake in the company to 5,894 shares, valued at approximately $1.14 million. Key Takeaways Evan Pickering, AppFolio's general counsel, sold 661 shares of Class A Common Stock on August 5. The transaction was automated under a Rule 10b5-1 plan adopted by Pickering on March 13. Pickering's remaining stake...

Kura Oncology CEO Purchases Approximately 100,000 Shares, Stock Gains About 9%

Image
Kura Oncology CEO Purchases Approximately 100,000 Shares, Stock Gains About 9% THE MONEYWISE JOURNAL  ·  finance  ·  Tuesday, August 25, 2026 Following the public disclosure, Kura Oncology’s share price rose about 9 %. By MoneyWise Guide Troy Edward Wilson, who serves as President, Chairman, and Chief Executive Officer of Kura Oncology, Inc., bought roughly 100,000 shares of the company’s common stock, a transaction disclosed in an SEC Form 4 filing. Following the public disclosure, Kura Oncology’s share price rose about 9 %. Key Takeaways Troy Edward Wilson bought roughly 100,000 Kura Oncology shares. The purchase was reported through an SEC Form 4 filing. Kura Oncology’s stock jumped approximately 9 % after the filing became public. Wilson holds the titles of President, Chairman, and CEO of the clinical‑stage biopharma. Kura Oncology is headquartered in San Diego. Metric Value Why it matters Insider buyer...

Chime Financial's Insider Filings: What You Need to Know After a Strong Quarter

Image
Chime Financial's Insider Filings: What You Need to Know After a Strong Quarter THE MONEYWISE JOURNAL  ·  finance  ·  Wednesday, August 12, 2026 The company also made significant changes, cutting about 10% of its staff and parting with its finance chief. By MoneyWise Guide Chime Financial, a digital-first fintech platform, reported a strong second quarter with 27% revenue growth to $670 million and a GAAP profit of $28 million. The company also made significant changes, cutting about 10% of its staff and parting with its finance chief. Amidst this backdrop, Amine Asmerom, chief accounting officer at Chime Financial, sold 10,000 shares of Class A Common Stock on August 6, pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025. Key Takeaways Chime Financial reported a strong second quarter with 27% revenue growth to $670 million and a GAAP profit of $28 million. Amine Asmerom, chief accounting officer, sol...

**Executive Insider Trading: Tenet Healthcare EVP, CIO Arbour Sells $2.65M in Stock**

Image
As a personal finance and investing expert, I always keep a close eye on insider trading activities. These actions often provide valuable insights into a company's performance and future prospects. In this article, we'll delve into a recent insider trading event involving Tenet Healthcare EVP, CIO Arbour, who has sold $2.65 million worth of stock. Background on Tenet Healthcare Tenet Healthcare is a leading healthcare services company that operates hospitals, medical facilities, and outpatient centers across the United States. The company has been navigating a challenging industry landscape, with rising costs, increasing competition, and shifting reimbursement models. Despite these challenges, Tenet Healthcare has demonstrated resilience and continues to expand its services. Insider Trading Activity On [date], Tenet Healthcare EVP, CIO Arbour sold 30,000 shares of the company's common stock at an average price of $88.33 per share. This transaction resulted in a total ...

Form 144 ASBURY AUTOMOTIVE GROUP For: 30 July

Image
Understanding the Importance of Form 144 As an investor, you're constantly on the lookout for opportunities to grow your portfolio. One way to do this is by keeping up with the latest news and trends in the automotive industry. In this article, we'll be taking a closer look at Form 144, specifically the ASBURY AUTOMOTIVE GROUP filing on 30 July. By the end of this article, you'll have a better understanding of what this filing means and how it can impact your investments. What is Form 144? Form 144 is a notification filed with the Securities and Exchange Commission (SEC) by a company or its insiders to report the sale or purchase of their own securities. This form is required by the SEC to maintain transparency and ensure that investors have access to accurate information about a company's financial dealings. The information contained in Form 144 is publicly available and can be accessed through the SEC's website or through various financial databases. By an...

DoorDash Director Andy Fang Sells 15,000 Shares for $3.2 Million

Image
DoorDash Director Andy Fang Sells 15,000 Shares for $3.2 Million THE MONEYWISE JOURNAL  ·  finance  ·  Tuesday, August 11, 2026 This transaction was made under a Rule 10b5-1 plan, which was established five months prior to the sale. By MoneyWise Guide DoorDash Director Andy Fang recently sold 15,000 shares of Class A Common Stock in the company, netting him $3.2 million. This transaction was made under a Rule 10b5-1 plan, which was established five months prior to the sale. Fang's decision to sell shares may seem concerning, but it was a planned move to avoid the appearance of acting on inside information. Key Takeaways DoorDash Director Andy Fang sold 15,000 shares of Class A Common Stock for $3.2 million. The sale was made under a Rule 10b5-1 plan established five months prior to the transaction. Fang kept 75% of his holdings, indicating he remains bullish on the company's stock. Metric ...

CAT Stock Lifts Dow Jones With Massive Earnings Beat

Image
CAT Stock Lifts Dow Jones With Massive Earnings Beat THE MONEYWISE JOURNAL  ·  finance  ·  Wednesday, August 05, 2026 As you consider the implications of this development on your portfolio, it's essential to understand the context and details surr… By MoneyWise Guide The CAT stock, also known as Caterpillar Inc., has recently made headlines with its significant earnings beat, positively impacting the Dow Jones. As you consider the implications of this development on your portfolio, it's essential to understand the context and details surrounding this event. You can think of the Dow Jones as a barometer of the overall health of the stock market, comprising 30 major companies, including Caterpillar Inc. Caterpillar Inc.'s earnings beat has lifted the Dow Jones, indicating a positive trend in the stock market. Understanding the context and details of this event is crucial for making informed investment decisions. ...

Life360's Director Sells 4,000 Shares Amid 38% Revenue Growth

Image
Life360's Director Sells 4,000 Shares Amid 38% Revenue Growth THE MONEYWISE JOURNAL  ·  finance  ·  Thursday, August 06, 2026 This transaction is notable, especially given that Life360's revenue grew 38% in the first quarter, reaching $143 million. By MoneyWise Guide John Philip Coghlan, a director at Life360, Inc., sold 4,000 shares of common stock on August 3, 2026, at a weighted average sale price of $54.82, according to an SEC Form 4 filing. This transaction is notable, especially given that Life360's revenue grew 38% in the first quarter, reaching $143 million. You can use this information to inform your investment decisions and consider the implications of this sale on your portfolio. Key Takeaways: Life360 director John Philip Coghlan sold 4,000 shares of common stock on August 3, 2026. The sale was made at a weighted average price of $54.82 per share, with the post-transaction value being $56.31 per share. ...

CoreWeave EVP Chen Goldberg Sells $438 in Stock

Image
CoreWeave EVP Chen Goldberg Sells $438 in Stock THE MONEYWISE JOURNAL  ·  finance  ·  Saturday, October 03, 2026 Key Takeaways Chen Goldberg, EVP of CoreWeave, sold $438 in company stock. By MoneyWise Guide CoreWeave Executive Vice President Chen Goldberg sold $438 worth of company shares. Key Takeaways Chen Goldberg, EVP of CoreWeave, sold $438 in company stock. The transaction involved CoreWeave shares. Executive stock sales are common for liquidity or portfolio management. Metric Value Why it matters Person Chen Goldberg Executive Vice President of CoreWeave Company CoreWeave The firm whose shares were sold Amount $438 Value of shares sold What Is a Stock Sale? When a company insider, such as an executive, sells shares, the transaction is recorded in public filings. The sale reduces the insider’s ownership stak...

Pfizer Just Hit a 52‑Week High. Is the Turnaround Finally Real?

Image
Pfizer Just Hit a 52‑Week High. Is the Turnaround Finally Real? THE MONEYWISE JOURNAL  ·  finance  ·  Saturday, October 31, 2026 Key Takeaways Shares are up 20% for the current calendar year. By MoneyWise Guide Pfizer’s stock has climbed 20% year‑to‑date and has recently broken through a new 52‑week high, signaling a notable shift in market sentiment toward the pharmaceutical giant. Key Takeaways Shares are up 20% for the current calendar year. The stock reached a fresh 52‑week high. These moves suggest renewed investor confidence in Pfizer’s prospects. Metric: Year‑to‑date share performance | Value: +20% | Why it matters: Indicates strong recent buying pressure. Metric: 52‑week high | Value: New peak reached | Why it matters: Shows the stock is trading at its highest level in the past year. What the Stock Movement Indicates The 20% rise in Pfizer’s share price this year reflects a broad...